[Inhibition of pyruvate and alpha ketoglutarate oxidation in the nephrotic syndrome following daunomycin administration in the rat glomerulus].
D000818:Animals; D003630:Daunorubicin / Q000008:administration & dosage / Q000633:toxicity*; D007656:Ketoglutaric Acids / Q000378:metabolism*; D007678:Kidney Glomerulus / Q000378:metabolism*; D009404:Nephrotic Syndrome / Q000139:chemically induced / Q000378:metabolism*; D010084:Oxidation-Reduction; D011773:Pyruvates / Q000378:metabolism*; D051381:Rats
D007656:Ketoglutaric Acids; D011773:Pyruvates; D003630:Daunorubicin
Hemmung der Pyruvat und alpha Ketoglutarat Oxydation beim nephrotischen Syndrom nach Daunomycin applikation im Ratten glomerulum.